Nymox Pharmaceutical Corporation announced effective June 28, 2022, accepted the resignation of Erik Danielsen as Chief Financial Officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 USD | -.--% | +8.38% | -55.93% |
1st Jan change | Capi. | |
---|---|---|
-55.93% | 24.27M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- NYMXF Stock
- News Nymox Pharmaceutical Corporation
- Nymox Pharmaceutical Corporation Announces Resignation of Erik Danielsen as Chief Financial Officer